Immediate Impact
65 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Works of Alexandra McMellen being referenced
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alexandra McMellen | 230 | 95 | 37 | 113 | 12 | 316 | |
| Rong Liu | 216 | 85 | 31 | 93 | 15 | 335 | |
| Gudrun Hager | 168 | 108 | 43 | 108 | 14 | 346 | |
| Qinghua Xi | 218 | 92 | 25 | 76 | 17 | 282 | |
| Ilenia Pellarin | 240 | 95 | 17 | 104 | 12 | 316 | |
| Martin Hellriegel | 225 | 103 | 30 | 62 | 13 | 369 | |
| Yiping Wen | 230 | 101 | 29 | 122 | 10 | 293 | |
| Ross Wanner | 258 | 86 | 31 | 191 | 13 | 354 | |
| Alessandra Dall’Acqua | 253 | 145 | 37 | 103 | 14 | 367 | |
| Tracy Litzi | 189 | 63 | 49 | 109 | 14 | 308 | |
| Junjie Qu | 266 | 52 | 27 | 196 | 14 | 360 |
All Works
Login with ORCID to disown or claim papers
Loading papers...